Delafloxacin Meglumine
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Treatment of common respiratory tract infections.
Journal: The Medical letter on drugs and therapeutics
Published: April 11, 2023
Antibacterial drugs for community-acquired pneumonia.
Journal: The Medical letter on drugs and therapeutics
Published: January 29, 2021
Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections.
Journal: Drugs
Published: July 16, 2020
Acute bacterial skin and soft tissue infections: new drugs in ID armamentarium.
Journal: Journal of community hospital internal medicine perspectives
Published: June 18, 2019
Delafloxacin meglumine for the treatment of acute bacterial skin and skin structure infections (ABSSSI).
Journal: Drugs of today (Barcelona, Spain : 1998)
Published: December 13, 2018
BaxdelaTM (Delafloxacin): A Novel Fluoroquinolone for the Treatment of Acute Bacterial Skin and Skin Structure Infections.
Journal: P & T : a peer-reviewed journal for formulary management
Published: November 10, 2018
Delafloxacin (Baxdela) for Skin Infections.
Journal: American family physician
Published: September 15, 2018
In brief: More fluoroquinolone warnings.
Journal: The Medical letter on drugs and therapeutics
Published: August 23, 2018
Comparison table: some antibiotics for MRSA skin and skin structure infections.
Journal: The Medical letter on drugs and therapeutics
Published: April 11, 2018
Comparison table: some systemic fluoroquinolones.
Journal: The Medical letter on drugs and therapeutics
Published: April 11, 2018
Delafloxacin meglumine, Meropenem trihydrate/vaborbactam, Secnidazole, and Benznidazole.
Journal: Journal of the American Pharmacists Association : JAPhA
Published: March 07, 2018
Last Updated: 04/28/2026